prognost factor outcom surviv second-look laparotomi patient advanc ovarian carcinoma ovarian cancer iib-iv pre-treat variabl variabl second-look laparotomi prognost influenc outcom patient surviv second-look laparotomi patient subject random trial sequenti versu combin chemotherapi overal median surviv second-look laparotomi month logist regress analysi stage hysterectomi plu bilater salpingo-oophorectomi omentectomi signific prognost covari second-look laparotomi outcom cox multivari stepwis analysi independ prognost factor surviv second-look laparotomi secondari residu tumor size pre-treat histolog differenti grade perform statu high differenti grade good perform statu start therapi prolong effect surviv second-look laparotomi prognost power pre-treat variabl addit secondari residu tumor size variabl surviv rate second-look laparotomi high- low-risk patient second-look laparotomi prognost inform patient advanc ovarian carcinoma benefit term surviv unclear 